Khiron Appoints Chris Naprawa as New President

Published: June 26, 2018

Khiron Appoints Chris Naprawa as New President

Khiron Life Sciences Corp., a Canadian integrated medical cannabis company with its core operations in Colombia, announced today the appointment of Chris Naprawa as President, effective immediately. Mr. Naprawa, who will report to Alvaro Torres, CEO, will lead Khiron’s capital markets activities, including outreach to existing and potential shareholders in Canada and internationally. This appointment is expected to increase the Company’s visibility amongst institutional investors and provides greater depth of management expertise in corporate finance, investor engagement, and mergers and acquisitions.

“Mr. Naprawa is a proven leader who brings outstanding execution strength to the Khiron team,” said Mr. Alvaro Torres, CEO of Khiron, ” His rare combination of skill sets, both as a capital markets professional and developer of growth companies, positions us with the ability to further focus our business activities. On behalf of our management team and board, I welcome Mr. Naprawa to our team.”

Mr. Naprawa brings extensive institutional capital markets experience to the Company. Prior to joining Khiron, Mr. Naprawa was Partner at Sprott Capital Partners, Head of Equity Sales at Macquarie Canada, Head of Equity Sales and Trading at Dundee Securities, and Managing Director at Primary Capital. He was also previously founder and CEO of Startcast Solutions, a company successfully sold to a large telecommunications company. Mr. Naprawa holds a Bachelor of Arts from Queen’s University.

“This is a remarkable time for the medical cannabis industry internationally, with regions such as Latin America representing a large addressable market potential,” Mr. Chris Naprawa, President of Khiron, stated, “This is similar to the market potential of Canada 5 years ago. I personally look forward to deploying my extensive expertise and relationships to help develop Khiron’s capital market activities. I am delighted to take on this role and work with the accomplished team members of the Company.”